Cambium Bio Limited (ASX:CMB)
Australia · Delayed Price · Currency is AUD 0.4200
0.00 (0.00%)
At close: Oct 27, 2026
Cambium Bio Market Cap
Cambium Bio has a market cap or net worth of 12.36 million as of October 29, 2026. It is the 42,210th most valuable company in the world and the 1,240th biggest in Australia. Its market cap has increased by 12.12% in one year.
Market Cap
12.36M
Enterprise Value
11.40M
Revenue
1.23M
Global Rank
Country Rank
#1,240 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2024, Cambium Bio's market cap has increased from 7.97M to 12.36M, an increase of 55.15%. That is a compound annual growth rate of 18.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 12.36M | 14.51% |
| Dec 31, 2025 | 10.80M | 103.21% |
| Dec 31, 2024 | 5.31M | -33.33% |
| Apr 5, 2024 | 7.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 18.19M |
| Imugene | 18.12M |
| Radiopharm Theranostics | 17.35M |
| ReNerve | 15.51M |
| Noxopharm | 15.05M |
| EZZ Life Science Holdings | 14.59M |
| Patrys | 14.56M |
| Ceryvyn Therapeutics | 13.68M |